CLVS

Clovis Oncology, Inc. - Common Stock

$64.00 +$1.47 +2.30%



Shares Bought10
Shares Sold10
Total20
Shares Owned0
Last Price$64.00
Total Return$8.41
Range Today$62.50 - $64.41
52 Week Range$35.38 - $99.45
Open$62.60
Market Cap$3.06B
Volume/Average425.31K/1.86M
P/E Ratio-
Dividend/Yield-




Clovis Oncology, Inc. engages in the acquisition, development, and commercialization of anti-cancer agents. Its marketed product, Rubraca, seeks to treat patients with deleterious BRCA mutation associated advanced ovarian cancer, who have been treated with two or more chemotherapies. It also has product candidates, namely Rociletinib and Lucitanib. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
09-29-17 13:14 10-12-17 14:53 $80.84 $83.00 +$2.16 +2.67% unholyurinal
09-28-17 21:00 10-12-17 14:46 $80.51 $82.85 +$2.34 +2.91% unholyurinal
07-13-17 18:14 07-14-17 15:32 $90.55 $94.13 +$3.58 +3.95% funkmasterflexion thetoastyj
09-28-17 16:39 10-12-17 14:54 $79.94 $83.02 +$3.08 +3.85% genovahero
09-28-17 21:11 10-12-17 14:50 $80.84 $82.71 +$1.87 +2.31% unholyurinal
09-29-17 13:11 10-12-17 14:51 $80.84 $82.76 +$1.92 +2.38% unholyurinal
11-27-17 18:49 11-29-17 16:46 $58.99 $59.86 +$0.87 +1.48% funkmasterflexion
09-28-17 21:05 10-12-17 14:48 $80.84 $82.81 +$1.97 +2.44% unholyurinal
07-13-17 16:58 07-24-17 18:09 $89.78 $86.10 -$3.68 -4.10% funkmasterflexion discchoco buffalo_biscuit
07-13-17 18:09 07-25-17 15:38 $90.11 $84.40 -$5.70 -6.33%